Radical cystectomy with super-extended lymphadenectomy: Impact of separate vs en bloc lymph node submission on analysis and outcomes

BJU International

Volumn 117, Issue 2, 2016, Pages 253-259

  Zehnder, Pascal ^a,b   Moltzahn, Felix ^b   Mitra, Anirban P ^a   Cai, Jie ^a   Miranda, Gus ^a   Skinner, Eila C ^a   Gill, Inderbir S ^a   Daneshmand, Siamak ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

cystectomy; lymph node density; lymphadenectomy; outcome; separate packets

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CYSTECTOMY; EN BLOC SUBMISSION TECHNIQUE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INCIDENCE; LYMPH NODE DENSITY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SEPARATE SUBMISSION TECHNIQUE; SURVIVAL RATE; TISSUE PREPARATION; BLADDER TUMOR; LABORATORY DIAGNOSIS; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; PELVIS; PROCEDURES; REPRODUCIBILITY; SURVIVAL ANALYSIS; TRANSITIONAL CELL CARCINOMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PELVIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SPECIMEN HANDLING; SURVIVAL ANALYSIS; URINARY BLADDER NEOPLASMS;

EID: 84954374079     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12956     Document Type: Article

References (24)

1. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF,. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002; 167: 1295-1298
2. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004; 22: 2781-2789
3. Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM,. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 2006; 176: 53-7
4. Stein JP, Cai J, Groshen S, Skinner DG,. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. J Urol 2003; 170: 35-41
5. Stein JP, Penson DF, Cai J, et al. Radical cystectomy with extended lymphadenectomy: evaluating separate package versus en bloc submission for node positive bladder cancer. J Urol 2007; 177: 876-8
6. Bergkvist A, Ljungqvist A, Moberger G,. Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130: 371-378
7. Stenzl A, Cowan NC, De Santis M, et al. Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol 2011; 59: 1009-1018
8. Zehnder P, Studer UE, Skinner EC, et al. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study. J Urol 2011; 186: 1261-1268
9. LEA. Available at: http://dgu.clinicalsite.org/de/cat/423/trial/1149. Accessed November 2014
10. SWOG S. Available at: http://www.swog.org/Visitors/newsletters/2011/08/index.asp?a=s1011. Accessed November 2014
11. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK,. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000; 85: 817-823
12. Seiler R, Thalmann GN, Zehnder P,. Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution. Res Rep Urol 2013; 5: 121-128
13. Weingartner K, Ramaswamy A, Bittinger A, Gerharz EW, Voge D, Riedmiller H,. Anatomical basis for pelvic lymphadenectomy in prostate cancer: results of an autopsy study and implications for the clinic. J Urol 1996; 156: 1969-1971
14. Bochner BH, Cho D, Herr HW, Donat M, Kattan MW, Dalbagni G,. Prospectively packaged lymph node dissections with radical cystectomy: evaluation of node count variability and node mapping. J Urol 2004; 172: 1286-1290
15. Svatek R, Zehnder P,. Role and extent of lymphadenectomy during radical cystectomy for invasive bladder cancer. Curr Urol Rep 2012; 13: 115-121
16. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE,. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873-8
17. Dorin RP, Daneshmand S, Eisenberg MS, et al. Lymph node dissection technique is more important than lymph node count in identifying nodal metastases in radical cystectomy patients: a comparative mapping study. Eur Urol 2011; 60: 946-952
18. Herr HW,. Superiority of ratio based lymph node staging for bladder cancer. J Urol 2003; 169: 943-945
19. Kurahashi T, Hara I, Oka N, Kamidono S, Eto H, Miyake H,. Detection of micrometastases in pelvic lymph nodes in patients undergoing radical cystectomy for locally invasive bladder cancer by real-time reverse transcriptase-PCR for cytokeratin 19 and uroplakin II. Clin Cancer Res 2005; 11: 3773-3777
20. Wu X, Kakehi Y, Zeng Y, Taoka R, Tsunemori H, Inui M,. Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20. J Urol 2005; 174: 2138-42
21. Autenrieth M, Nawroth R, Semmlack S, Gschwend JE, Retz M,. [Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes]. Urologe A 2008; 47: 1157-1161
22. Rink M, Shariat SF, Xylinas E, et al. Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy? World J Urol 2012; 30: 807-814
23. Poulsen AL, Horn T, Steven K,. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-9
24. Shirotake S, Kikuchi E, Matsumoto K, et al. Role of pelvic lymph node dissection in lymph node-negative patients with invasive bladder cancer. Jpn J Clin Oncol 2010; 40: 247-251